Bionow | News

New NHC Service launched to accelerate gene therapy development

Sep 26th 2024

The National Horizons Centre at Teesside University has launched VecTUs, a new research-grade BioVector production service.

Northern Gritstone invests in Pencil Biosciences, developer of novel gene editin...

Oct 3rd 2023

Pencil Biosciences is developing a fully synthetic gene modulation and editing platform that will have impact across a wide range of applications, including new therapeutic options for patie...

Biocair takes home two awards at the prestigious Asia-Pacific Cell & Gene Therap...

Sep 22nd 2023

Biocair, a distinguished life science logistics company with over three decades of expertise, was announced as the winner of two awards at the esteemed Asia-Pacific Cell & Gene Therapy Excel...

Celebrating 20 years at Biocair: An interview with Christopher Good

Aug 24th 2023

Christopher Good, Director of Cell and Gene Therapy Logistics at Biocair, reflects on his last two decades with the company and how the industry has changed during that time.

BIomatics to support Cell and Gene Therapy Catapult to accelerate programme of O...

Aug 9th 2023

Business transformation consultancy Biomatics is to work alongside innovation and technology organisation, the Cell and Gene Therapy Catapult.

Biocair develops dedicated team for cell and gene therapy logistics

Dec 5th 2022

Biocair has invested heavily in the creation of a specialist logistics team to meet the complex needs of the rapidly expanding cell and gene therapy sector.

UK Supplier expands to provide Chemically Defined & Serum-Free Cell Media Soluti...

Nov 15th 2022

BioPharma Dynamics, a leading life sciences solution provider, proudly expand their extensive portfolio for the Cell & Gene Therapy market to offer a range of chemically defined T-Cell Media...

BioPharma Dynamics present their comprehensive process solutions for the Cell an...

Mar 17th 2021

Curating their extensive portfolio of process solutions to serve a multitude of cell therapy applications, BioPharma Dynamics are utilising their infrastructure and industry experience, to s...

Atelerix Consortium Awarded £267,000 Innovate UK Grant for collaboration with t...

Aug 21st 2019

Cambridge and Newcastle, UK, 21st August 2019: Atelerix, pioneers in the storage and transport of cells at room temperature, today announces that it has been awarded a grant of £267,000 fro...

Cobra Biologics expands DNA vaccines, gene and immunotherapy production in Swede...

Apr 11th 2019

ATMP (Advanced therapy medicinal product) specialist Cobra Biologics builds Sweden’s first 500 litre bioreactor investing €20 million at its Matfors facility in Sundsvall.

Cobra Biologics, Pall Corporation and the Cell and Gene Therapy Catapult Win £1...

Nov 26th 2018

Cobra Biologics, an international contract development and manufacturing organisation with a focus on advanced therapy medicinal products has won a £1.5m shared grant from Innovate UK.

Cobra Biologics Receives the Queen’s Award for Enterprise in International Tra...

Apr 23rd 2018

Cobra Biologics (“Cobra”) a leading international contract development and manufacturing organisation (“CDMO”), today announced that it has been awarded the Queen’s Award 2018 for ...

News